Status:
UNKNOWN
Thyroid Cancer and (FDG)PET/CT Scan
Lead Sponsor:
Assiut University
Conditions:
Thyroid Cancer
Eligibility:
All Genders
10-80 years
Brief Summary
Background and Rational (Introduction) Differentiated thyroid carcinoma (DTC) have favorable prognosis. Overall 10-year survival is 93% for papillary carcinoma, and 85% for follicular carcinoma(1). ...
Detailed Description
Design and Methodology Study design:- It's a prospective study for the group of patients who will do F-18FDG PET/CT scan after negative whole body scan with elevated serum thyroglobulin Antibody or ...
Eligibility Criteria
Inclusion
- · This study will include thyroid cancer patients of wide age ranges, who underwent total thyroidectomy with negative radioactive iodine whole body scan (I-WBS) and elevated stimulated thyroglobulin (sTg) or thyroglobulin antibody (TgAb) levels.
- Patients able to sleep in a fixed position for 20 minutes.
Exclusion
- Patients unable to sit calm without movement during imaging.
- Severely ill patients.
- Patients' blood glucose \> 11.1 mmol/L (200 mg/dL) measured by glucometer immediately prior to scan.
- Pregnancy
Key Trial Info
Start Date :
October 30 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04128631
Start Date
October 30 2019
End Date
December 1 2020
Last Update
October 16 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.